Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity

Overview of attention for article published in Frontiers in endocrinology, June 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,462 followers.

Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity https://t.co/FUtAwktP9s

05 Jul 2022

Reply Repost Favourite

Glad to share our paper: The favorable genotypes of type III interferon, which have a beneficial role in anti-virus function, could have a pathologic role in people with obesity and chronic inflammation. In-depth experimental studies are needed.

02 Jul 2022

Reply Repost Favourite

New Research: Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity: Background Studies have indicated that the chronic state of inflammation caused by obesity leads to dyslipidemia.… https://t.co/i0CGB5S2AG

17 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.